Compare TMP & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMP | OPK |
|---|---|---|
| Founded | 1836 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 1995 |
| Metric | TMP | OPK |
|---|---|---|
| Price | $72.58 | $1.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $74.00 | $2.28 |
| AVG Volume (30 Days) | 61.1K | ★ 3.6M |
| Earning Date | 01-30-2026 | 10-29-2025 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | ★ 27.02 | N/A |
| EPS | ★ 5.90 | N/A |
| Revenue | $316,920,000.00 | ★ $642,067,000.00 |
| Revenue This Year | $16.28 | N/A |
| Revenue Next Year | $1.90 | N/A |
| P/E Ratio | $12.33 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $54.16 | $1.11 |
| 52 Week High | $77.33 | $2.04 |
| Indicator | TMP | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 36.18 |
| Support Level | $73.61 | $1.29 |
| Resistance Level | $75.23 | $1.34 |
| Average True Range (ATR) | 1.81 | 0.05 |
| MACD | -0.56 | -0.00 |
| Stochastic Oscillator | 5.82 | 5.91 |
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.